Navigation Links
VioQuest Pharmaceuticals Announces Dosing of First Patient in Phase IIa Solid Tumor Study for Lenocta(TM), a Novel Protein Tyrosine Phosphatase Inhibitor
Date:11/26/2007

BASKING RIDGE, N.J., Nov. 26 /PRNewswire-FirstCall/ -- VioQuest Pharmaceuticals (OTC Bulletin Board: VQPH) today announced the initiation of a Phase IIa study of Lenocta(TM) (sodium stibogluconate), a novel protein tyrosine phosphatase inhibitor, in combination with interferon alpha, an immune stimulant approved for the treatment of hepatitis C, hepatitis B and a number of cancers. The open-label Phase IIa study is designed to enroll at least 12 more patients.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070117/NYW085LOGO )

The Phase IIa trial will evaluate the clinical efficacy and biological effectiveness of Lenocta at the highest tolerable dose in combination with interferon alpha in patients with advanced-stage solid tumors.

"We have reached a significant milestone in the development of Lenocta as a potential cancer therapy with the initiation of this trial," said Michael D. Becker, President and Chief Executive Officer of VioQuest Pharmaceuticals. "We will continue to advance our portfolio of novel compounds for various cancer indications into clinical development, the goal of this drug development organization."

Razelle Kurzrock M.D., Professor of Medicine Chair, Department of Investigational Cancer Therapeutics at The University of Texas M.D. Anderson Cancer Center is the lead principal investigator for the study, while Aung Naing M.D. of the same institution and Claire Verschraegen M.D. of The University of New Mexico Cancer Center are participating co-principal investigators.

Data from the recently concluded Phase I trial for Lenocta demonstrated pharmacodynamic activity in some solid tumors as demonstrated by increases in the activities of natural killer cells, CD8 and type II dendritic cells.

About Lenocta

Lenocta, a pentavalent antimonial originally used for the treatment of the parasitic disease leishmaniasis, is an
'/>"/>

SOURCE VioQuest Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. VioQuest Pharmaceuticals Completes Enrollment of Phase I Trial of Lenocta(TM)
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
6. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
7. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
8. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
11. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... analysis of Centers for Medicare and Medicaid Services, (CMS) ... percent of seniors chose lower-cost preferred pharmacy plans that ... The findings were released by Drug Channels . ... of Medicare Part D," said Pharmaceutical Care Management Association ...
(Date:1/23/2015)... a third of reproductive-aged women enrolled in Medicaid, and more ... prescription for an opioid pain medication each year during 2008-2012, ... Weekly Report (MMWR). Opioids are typically prescribed ... They are also found in some prescription cough medications. The ...
(Date:1/23/2015)... baseball,s all-time hits leader, is the new spokesperson for the ... has announced. "Pete,s a Hall of Famer in ... board with Myoflex," said Ducere Pharma Chief Executive Officer ... known across all generations. The passion and intensity that Pete ...
Breaking Medicine Technology:New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3Pete Rose bets on Myoflex to relieve aches and pains 2
... historic open letter to the World Health Organization ... Drugs (CoMeD) , and the United Methodist Women are seeking ... vaccines.  Currently, the mercury-based preservative Thimerosal, which is 49% mercury ... much of the world, despite the fact that it is ...
... Texas, March 15, 2012  OxySure® Systems, Inc. (OTCBB: ... emergency oxygen solutions with its "oxygen from powder" ... a Supplier Agreement ("Agreement") with W.W. Grainger, Inc. ... (Logo:  http://photos.prnewswire.com/prnh/20120315/DA71084LOGO ) In terms ...
Cached Medicine Technology:Global Call for Mercury-free Vaccines Issued 2OxySure Systems Announces Supplier Agreement With Grainger 2OxySure Systems Announces Supplier Agreement With Grainger 3
(Date:1/22/2015)... Padre Murphy's and Owner Tom Boyle in ... Player Health Alliance (PPHA). The PPHA's passion for others' ... including NFL greats, treated for obstructive sleep apnea (OSA) has ... the cause in the valley. The most recent plans for ...
(Date:1/22/2015)... The Incredible Bulk is a revolutionary method put ... muscle by up to 30lbs in less than 12 weeks ... Stan Stevenson, prompting an investigative review. , “Our Incredible ... diet formula that allows the body to pack on a ...
(Date:1/22/2015)... January 22, 2015 Blue Cross and Blue ... who exemplify what it means to “Live Fearless.” ... people to share their stories about how they or someone ... inspired others by living in the moment. By telling these ...
(Date:1/22/2015)... New York (PRWEB) January 22, 2015 The ... ) in the U.S. District Court, Southern District of West ... Bard, Inc. in that proceeding’s first bellwether trial. In an ... for a new trial after finding that C.R. Bard had ...
(Date:1/22/2015)... TX (PRWEB) January 22, 2015 A ... issue of experience and person-centeredness in the long-term care ... towards action across the continuum. The paper, “The Power ... Continuum,” engages perspectives and practices of the patient, resident ...
Breaking Medicine News(10 mins):Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3
... release is available in French . ... of Canada today announced a new study that will ... David Sweet, Member of Parliament for Ancaster-Dundas-Flamborough-Westdale, made the ... of Health. , "This long-term study of 50,000 Canadians ...
... Pa., May 21 Elimination of funding ... proposed by the Senate Republican budget plan would end ... the rate of health care cost increases, improving quality ... said today.For the past two years the small "think ...
... MT. LAUREL, N.J., May 21 The Commission for ... Second Annual Patricia McCollom $1,000 Scholarship. August 1 is ... can be used to help cover the cost of ... will announce the scholarship winner in October, during Case ...
... Offer Unique Mobile Communication Solution That Improves Patient ... TCS Healthcare Technologies (TCS), an industry ... applications, announced today that they have added an ... care management software platform, supported by Life: WIRE(TM) ...
... and Boston believe they may have identified a gene that ... troublesome problem for people with diabetes. , The liver is ... (glucose) levels fall, the liver makes and releases more. In ... stop making sugar when it should, so blood sugar levels ...
... Foundation, Group Health, The Technology Alliance, UW TechTransfer ... An alliance of leaders in health care, business, ... chapter of the Partnership to Fight Chronic Disease ... 17th U.S. Surgeon General (2002-2006), President of the ...
Cached Medicine News:Health News:Government of Canada supports research to improve the health of future generations of Canadians 2Health News:Senate Republican Budget Would End Health Initiatives That Save Lives and Money 2Health News:Senate Republican Budget Would End Health Initiatives That Save Lives and Money 3Health News:Senate Republican Budget Would End Health Initiatives That Save Lives and Money 4Health News:CCMC Accepting Applications for Second Annual Patricia McCollom Scholarship Through Aug. 1 2Health News:TCS Healthcare Technologies to Offer Interactive Text Messaging As Part of Its Care Management Software Platform 2Health News:TCS Healthcare Technologies to Offer Interactive Text Messaging As Part of Its Care Management Software Platform 3Health News:Regulating the sugar factory in diabetes 2Health News:Technology Leaders, Patient Groups and Community Advocates Launch Effort to Tackle Chronic Disease Crisis in Washington State 2Health News:Technology Leaders, Patient Groups and Community Advocates Launch Effort to Tackle Chronic Disease Crisis in Washington State 3Health News:Technology Leaders, Patient Groups and Community Advocates Launch Effort to Tackle Chronic Disease Crisis in Washington State 4
... have been designed to optimize the accuracy ... our tip products is widely recognized by ... has been extended over the years and ... and special tips including filter tips, certified ...
... tips. Each box contains 1000 tips (5 bags ... tips (4 bags of 50 tips). Also available ... per pack. Bulk Packs are sealed with a ... quick access to Gilsons Diamond Tips. Bulk Packs ...
Volume range 0.2-10 l. Designed for pipetting micro-sized drops. Ideal for use with micro volume Finnpipettes....
... designed to optimize the accuracy and precision ... products is widely recognized by customers throughout ... extended over the years and now covers ... tips including filter tips, certified pure tips, ...
Medicine Products: